Navigation Links
Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010
Date:2/1/2011

Neurovascular92893%2%Endoscopy2842696%6%Urology/Women's Health1271233%3%Neuromodulation86808%8%Subtotal2,0022,077(4)%(4)%Divested Businesses

02N/AN/AWorldwide$2,002$2,079(4)%(4)%Growth rates are based on actual, non-rounded amounts and may not recalculate precisely.

An explanation of the Company's use of these non-GAAP measures is provided at the end of this document.

BOSTON SCIENTIFIC CORPORATIONWORLDWIDE SALES

(Unaudited)ChangeYear EndedAs ReportedConstantDecember 31,CurrencyCurrencyin millions

20102009BasisBasisUnited States$4,335$4,675(7)%(7)%EMEA

1,7591,837(4)%(1)%Japan

968988(2)%(8)%Inter-Continental

7406779%1%International3,4673,502(1)%(3)%Subtotal7,8028,177(5)%(5)%Divested Businesses

411N/AN/AWorldwide$7,806$8,188(5)%(5)%ChangeYear EndedAs ReportedConstantDecember 31,CurrencyCurrencyin millions

20102009BasisBasisCardiac Rhythm Management$2,180$2,413(10)%(10)%Interventional Cardiology

2,6022,859(9)%(10)%Peripheral Interventions

6696611%0%Cardiovascular Group3,2713,520(7)%(8)%Electrophysiology147149(2)%(2)%Neurovascular340348(2)%(4)%Endoscopy1,0791,0067%6%Urology/Women's Health4814565%5%Neuromodulation3042857%7%Subtotal7,8028,177(5)%(5)%Divested Businesses

411N/AN/AWorldwide$7,806$8,188(5)%(5)%Growth rates are based on actual, non-rounded amounts and may not recalculate precisely.

An explanation of the Company's use of these non-GAAP measures is provided at the end of this document.
 

BOSTON SCIENTIFIC CORPORATIONNON-GAAP CONSTANT CURRENCY NET SALES RECONCILIATIONS

(Unaudited)Q4 2010 Net Sales as compared to Q4 2009ChangeEstimatedAs ReportedConstantImpact ofCurrencyCurrencyForeignin millions

BasisBasisCurrencyUnited States$(54)$(54)EMEA

(30)$

(30)Japan

(1)(22)21Inter-Continental

1028International(21)(20)(1)Subtotal(75)(74)(1)Divested Businesses

(2)(2)Worldwide$(77)$
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System
2. Boston Scientific Responds to DOJ Civil Lawsuit
3. Boston Scientific Announces First Use of Blazer® Open-Irrigated Catheter in U.S.
4. Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent
5. Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent
6. Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan
7. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2010 Financial Results
8. Boston Scientific to Acquire Atritech
9. Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease
10. Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA Article
11. Boston Scientific Completes Acquisition of Sadra Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013 In accordance with Rule 17.1 and Rule ... the United States Exchange Act, Echo Pharma Acquisition Limited ("Royalty ... Corporation (NYSE: ELN). Background On 2 ... offer for the entire of the issued and to be ... Offer").  On 20 May 2013, Royalty Pharma ...
(Date:5/23/2013)... 2013 3SBio Inc. (NASDAQ: ... China -based biotechnology company focused ... announced today that, at an extraordinary general meeting ... in favor of the proposal to authorize and ... merger dated February 8, 2013, among Decade Sunshine ...
(Date:5/23/2013)... May 23, 2013 Amgen (NASDAQ: AMGN ... Annual  Healthcare Conference on Thursday, May 30, 2013, at the ... at 9:20 a.m. Eastern Daylight Time. Arvind Sood ... present at the conference. Live audio of the presentation can ... www.amgen.com , under Investors. A replay of the webcast will ...
Breaking Medicine Technology:Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 93SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... N.J., Nov. 2, 2010 Regado Biosciences, Inc., a ... with active control agents, announced that Steven L. Zelenkofske, ... presented an abstract at the American College of Chest ... 2, 2010 in Vancouver, BC, Canada.  The abstract is ...
... Nov. 2, 2010 The Saudi Arabian National Guard ... an agreement with Varian Medical Systems and IMRIS, Inc., ... radiation therapy (MRgRT™). Under the agreement, Varian ... combines IMRIS, unique movable magnetic resonance imaging (MRI) technology ...
Cached Medicine Technology:Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010 2Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010 3Saudi Arabia's King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy 2Saudi Arabia's King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy 3Saudi Arabia's King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy 4
(Date:5/25/2013)... York (PRWEB) May 25, 2013 ... litigation underway in U.S. District Court, Western District of ... According to a Case Management Order issued on ... the filing of contested motions in the Actos bladder ... motions. (In re: Actos Product Liability Litigation, MDL No. ...
(Date:5/25/2013)... The report “Global Food Encapsulation Market (2012 – ... Materials, Packaging, & Geography: Trends & Forecasts” defines ... analysis and forecasting of the global revenue for ... restraining factors for the global food encapsulation markets ... market is segmented and revenue are forecasted on ...
(Date:5/25/2013)... 25, 2013 Providing patients with their best ... team of weight management professionals. But, aside from educating patients ... Diet Doc’s hCG diets also provide patients, who ... childhood like bullying, more control over their lives by achieving ... with the underlying factors of weight gain derived from earlier ...
(Date:5/25/2013)... New York, New York (PRWEB) May 25, 2013 ... patients who allegedly suffered serious, life-threatening episodes of internal bleeding ... federal litigation underway in U.S. District Court, Southern District of ... on the Court’s website, 818 Pradaxa side effect claims had ... 24, 2013. That’s up from 705 claims reported by ...
(Date:5/25/2013)... New York, NY (PRWEB) May 25, 2013 ... organization dedicated to brain cancer research and advocacy, comments ... for Extraterrestrial Physics, that shows incorporating cold atmospheric plasma ... glioblastoma cells. , According to a Science ... for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the ...
Breaking Medicine News(10 mins):Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2
... CLEVELAND, March 17 JumpStart Inc. ... the progress of high growth early-stage businesses, and ... capital and technology validation fund at Case Western ... $375,000 in Neuros Medical, Inc. , a Cleveland, ...
... Invasive Treatment for Prostate Cancer and Benign Prostatic ... 16 Mexico HIFU in conjunction with International ... a global leader in the development, manufacturing and ... will host the very first multiday Sonablate(R) HIFU ...
... PLYMOUTH MEETING, Pa., March 16 /PRNewswire-Asia-FirstCall/ -- BMP,Sunstone Corporation ... the "Company"),today announced that the Company is calling its ... 2009 (the "Original Notes"). In addition, the,Company announced ... -- Exchanged $1.0 million in principal amount ...
... BEACH, Fla., March 16 With a reputation as ... new initiative, MorseLife Learning Institute (MLI), will expand ... practices in leadership, healthcare and Kosher culinary.Already noted ... MorseLife to provide online and onsite clinical education ...
... ranked among Top 10 Companies for Supplier Diversity and for ... Care Service Corporation (HCSC) as one of its Top 50 ... In 2009, the company ranks 22, up 12 spots ... Top 10 Companies for Supplier Diversity as well as the ...
... elective medical proceduresEAGAN, Minn., March 16 Consumers can ... information through Care Comparison(R), a new online tool introduced ... Care Comparison allows nearly two million Blue Cross members ... as quality, safety and accessibility information for dozens of ...
Cached Medicine News:Health News:JumpStart and Case Technology Ventures Invest in Neuros Medical 2Health News:JumpStart and Case Technology Ventures Invest in Neuros Medical 3Health News:JumpStart and Case Technology Ventures Invest in Neuros Medical 4Health News:JumpStart and Case Technology Ventures Invest in Neuros Medical 5Health News:High Intensity Focused Ultrasound Physician Training Seminar in Mexico City 2Health News:BMP Sunstone Exchanges and Calls Outstanding Notes Due May 2009 2Health News:MorseLife Launches Learning Institute to Teach Best Practices in Leadership, Healthcare and Kosher Culinary 2Health News:Health Care Service Corporation Ranked as One of the Most Diverse Companies in the Country for 5th Consecutive Year 2Health News:Health Care Service Corporation Ranked as One of the Most Diverse Companies in the Country for 5th Consecutive Year 3Health News:Health Care Service Corporation Ranked as One of the Most Diverse Companies in the Country for 5th Consecutive Year 4Health News:Blue Cross Puts New Online Shopping Tool in Hands of Consumers 2Health News:Blue Cross Puts New Online Shopping Tool in Hands of Consumers 3
... Agility is positioned to support ... to reduce medication and other ... workflow for pharmacy support staff ... blood products, lab specimens and ...
... Context-sensitive medicine is the ability of medical ... pre-determined ways based on what is happening ... associations a Radianse indoor positioning solution (IPS) ... it requires identity, location and time to ...
... VerdaSee Intelli-Storeroom™ was developed to create physically ... entrances and exits are converted to RFID ... RFID readers and antennas by VerdaSee's Field ... affixed to assets that are to be ...
... ability to track the movement of ... assets can be done. VerdaSee's "intellishelvess" ... Continuous cycle counting is possible with ... (RFID) technology makes this possible. VerdaSee ...
Medicine Products: